Skip to main navigation Skip to search Skip to main content

Loss of response to infliximab is common amongst patients with inflammatory bowel disease and varies according to definition

  • S Sivanes
  • , A Davenport
  • , Arun Gupta

    Research output: Contribution to journalMeeting Abstractpeer-review

    Original languageEnglish
    Pages (from-to)146-146
    JournalJournal of Gastroenterology and Hepatology
    Publication statusPublished - 2016
    EventGastroenterological Society of Australia, Australian Gastroenterology Week 2016 - Adelaide, Australia, Australia
    Duration: 1 Jan 2016 → …

    Cite this